Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients

References

• Kuo YJ, Liu YJ, Way TD, et al. Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo. Exp Ther Med. 2017;13(6):3388–3396. doi:10.3892/etm.2017.4392
   PubMed Web of Science ®Google Scholar
• Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111–121. doi:10.1056/NEJMoa1300874
   PubMed Web of Science ®Google Scholar
• Shinjo K, Takeshita A, Sahara N, et al. Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment. Intern Med. 2005;44(8):818–824. doi:10.2169/internalmedicine.44.818
   PubMed Web of Science ®Google Scholar
• Wang H, Xi S, Liu Z, et al. Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Environ Toxicol. 2013;28(5):267–275. doi:10.1002/tox.20717
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang Y, Li J, et al. Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. Blood. 2010;115(9):1697–1702. doi:10.1182/blood-2009-07-230805
   PubMed Web of Science ®Google Scholar
• Flanagan B, Keber B, Mumford J, et al. Hematologic conditions: leukocytosis and leukemia. FP Essent. 2019;485:17–23.
   PubMedGoogle Scholar
• Mathews V, Desire S, George B, et al. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia. 2006;20:881–883. doi:10.1038/sj.leu.2404165
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming Y, Zhu H, Yang C, et al. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts. Drug Metab Rev. 2020;52(3):425–437. doi:10.1080/03602532.2020.1791173
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming Y, Wang C, Xu S. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation. Metallomics. 2018;10(6):828–837. doi:10.1039/C8MT00057C
   PubMed Web of Science ®Google Scholar
• Sui M, Zhang Z, Zhou J. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia. Chin Med J (Engl). 2014;127(19):828–837. doi:10.1039/C8MT00057C
   Web of Science ®Google Scholar
• Khairul I, Wang QQ, Jiang YH, et al. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget. 2017;8(14):23905–23906. doi:10.18632/oncotarget.14733
   PubMedGoogle Scholar
• Iriyama N, Yoshino Y, Yuan B, et al. Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient. J Hematol Oncol. 2012;5:1. doi:10.1186/1756-8722-5-1
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen Y, Meng H, et al. Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide. Leuk Lymphoma. 2013;54(9):2041–2046. doi:10.3109/10428194.2013.769222
   PubMed Web of Science ®Google Scholar
• Šlejkovec Z, Podgornik H, Černelč P, et al. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3. Biometal. 2016;29(1):107–118. doi:10.1007/s10534-015-9901-5
   PubMed Web of Science ®Google Scholar
• Akao Y, Yamada H, Nakagawa Y. Arsenic-induced apoptosis in malignant cells in vitro. Leuk Lymphoma. 2000;37(1):53–63. doi:10.3109/10428190009057628
   PubMed Web of Science ®Google Scholar
• Mathews VV, Paul MS, Abhilash M, et al. Mitigation of hepatotoxic effects of arsenic trioxide through omega-3 fatty acid in rats. Toxicol Ind Health. 2014;30(9):806–813. doi:10.1177/0748233712463778
   PubMed Web of Science ®Google Scholar
• Rech VC, Mezzomo NJ, Athaydes GA, et al. Thiol/disulfide status regulates the activity of thiol-containing kinases related to energy homeostasis in rat kidney. An Acad Bras Cienc. 2018;90(1):99–108. doi:10.1590/0001-3765201720160348
   PubMed Web of Science ®Google Scholar
• Jung K, Kwak M. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15(10):7266–7291. doi:10.3390/molecules15107266
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming Y, Wang QQ, Yang C, et al. Hyperthermia selectively destabilizes oncogenic fusion proteins. Blood Cancer Discov. 2021;2(4):388–401. doi:10.1158/2643-3230.BCD-20-0188
   PubMedGoogle Scholar
• Kitamura K, Minami Y, Yamamoto K, et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia. 2000;14:1743–1750. doi:10.1038/sj.leu.2401900
   PubMed Web of Science ®Google Scholar
• Kiguchi T, Yoshino Y, Yuan B, et al. Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia. Leuk Res. 2010;34(3):403–405. doi:10.1016/j.leukres.2009.08.001
   PubMed Web of Science ®Google Scholar
• Kann S, Estes C, Reichard JF, et al. Butylhydroquinone protects cells genetically deficient in glutathione biosynthesis from arsenite-induced apoptosis without significantly changing their prooxidant status. Toxicol Sci. 2005;87(2):365–384. doi:10.1093/toxsci/kfi253
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase3 in vitro. FEBS Lett. 1999;455(1):59–62. doi:10.1016/s0014-5793(99)00841-8
   PubMed Web of Science ®Google Scholar
• Gribble MO, Tang WY, Shang Y, et al. Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure. Arch Toxicol. 2014;88(2):275–282. doi:10.1007/s00204-013-1146-x
   PubMed Web of Science ®Google Scholar
• Howe CG, Niedzwiecki MM, Hall MN, et al. Folate and cobalamin modify associations between S-adenosylmethionine and methylated arsenic metabolites in arsenic-exposed Bangladeshi adults. J Nutr. 2014;144(5):690–697. doi:10.3945/jn.113.188789
   PubMed Web of Science ®Google Scholar